munjit, a bit harsh to compare STP with Medivac. Medivac is a start-up, with limited cash resources and like many start up's has a series of prospective revenue generating opportuntities. Stericorp on the other hand generates approx. $0.75m per month in net operating cashflow, with a GP Margin of 39%. At that rate, STP will generate an amount of net operating cash flow equal to Mediva'c total market cap in just under 12 months. Perhaps Medivac should be talking to Stericorp ?
also like FML, QUB, ACR, HSN
personal comments only. DYOR
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
70.5¢ |
Change
0.005(0.71%) |
Mkt cap ! $130.6M | |||
| Open | High | Low | Value | Volume |
| 71.5¢ | 72.0¢ | 68.0¢ | $269.3K | 386.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38864 | 69.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 70.5¢ | 16154 | 2 |
View Market Depth
| Last trade - 16.11pm 28/07/2025 (20 minute delay) ? |
| STP (ASX) Chart |